Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker
Cancer is a disease with abnormally proliferating cells and therefore proliferation rate is an important index for assessing tumour growth. Ki-67 is a commonly used proliferation marker considered to be an unfavourable prognostic marker in some tumors, while Thymidine kinase 1 (TK1) is an interestin...
Main Authors: | Jianjun Wang, Qi Liu, Xiaodie Zhou, Yan He, Qing Guo, Qunli Shi, Staffan Eriksson, Ji Zhou, Ellen He, Sven Skog |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-06-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317706479 |
Similar Items
-
Investigation on Cell Proliferation with a New Antibody against Thymidine Kinase 1
by: Naining Wang, et al.
Published: (2001-01-01) -
Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
by: Alexandra Schönherr, et al.
Published: (2004-01-01) -
Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase
by: Vannary Tieng, et al.
Published: (2016-01-01) -
Clinicopathological and Prognostic Value of Immunohistochemical Expression of CD44 (Stem Cell Marker) and Ki67 in Serous Ovarian Cancer
by: Taiseer R Ibrahim, et al.
Published: (2020-01-01) -
Proliferative index using Ki-67 index in reactive mesothelial versus metastatic adenocarcinoma cells in serous fluid
by: Noushin Afshar Moghaddam, et al.
Published: (2012-01-01)